Mitchell A. Garrison
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
-
- Acute Myeloid Leukemia Research 3
- Hematopoietic Stem Cell Transplantation 2
- Oncology 6
- HER2/EGFR in Cancer Research 1
- Co-authors
- Lisa A. Hammond (3 shared papers)Johann Sebastian De Bono (2 shared papers)Eric Keith Rowinsky (3 shared papers)Julie C. Smith (3 shared papers)Christopher B. Jones (2 shared papers)Alain C. Mita (1 shared paper)Samira K. Syed (1 shared paper)Geoffrey R. Weiss (1 shared paper)
- Journals
- Blood (5 papers)The Lancet Oncology (3 papers)Clinical Breast Cancer (1 paper)Journal of Clinical Oncology (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesSouth Africa
In The Last Decade
Mitchell A. Garrison
16 papers receiving 1.1k citations
Mitchell A. Garrison's Hit Papers
Peers
Comparison fields: 5 of 68
- Hematology 353
- Oncology 670
- Pulmonary and Respiratory Medicine 283
- Cancer Research 86
- Pathology and Forensic Medicine 81
Countries citing papers authored by Mitchell A. Garrison
This map shows the geographic impact of Mitchell A. Garrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell A. Garrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell A. Garrison more than expected).
Fields of papers citing papers by Mitchell A. Garrison
This network shows the impact of papers produced by Mitchell A. Garrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell A. Garrison. The network helps show where Mitchell A. Garrison may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitchell A. Garrison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study Hit paper breakdown → | 2018 | 496 |
| 2 | Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2019 | 316 |
| 3 | 2019 | 69 | |
| 4 | 2006 | 62 | |
| 5 | 2010 | 49 | |
| 6 | 2021 | 39 | |
| 7 | 2018 | 32 | |
| 8 | 2008 | 31 | |
| 9 | 2022 | 25 | |
| 10 | A Phase I and pharmocokinetic study of exatecan mesylate administered as a protracted 21-day infusion in patients with advanced solid malignancies. | 2003 | 15 |
| 11 | 2001 | 5 | |
| 12 | 2025 | 5 | |
| 13 | 2022 | 3 | |
| 14 | 2004 | 3 | |
| 15 | 2002 | 1 | |
| 16 | 2008 | 1 |
About Mitchell A. Garrison
Mitchell A. Garrison is a scholar working on Hematology, Oncology, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), Lung Cancer Treatments and Mutations (2 papers), Angiogenesis and VEGF in Cancer (1 paper), HER2/EGFR in Cancer Research (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Hematology (353 citations), Oncology (670 citations), Pulmonary and Respiratory Medicine (283 citations), Cancer Research (86 citations) and Pathology and Forensic Medicine (81 citations). Mitchell A. Garrison has collaborated with scholars based in United States and South Africa. Frequent co-authors include Lisa A. Hammond, Johann Sebastian De Bono, Eric Keith Rowinsky, Julie C. Smith, Christopher B. Jones, Alain C. Mita, Samira K. Syed, Geoffrey R. Weiss, Steve Weitman and Quincy Siu-Chung Chu. Their work appears in journals such as Blood, The Lancet Oncology, Clinical Breast Cancer, Journal of Clinical Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.